What are the types of thyroid cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There are four main types of thyroid cancer: papillary, follicular, medullary, and anaplastic thyroid cancer, with papillary being the most common type, accounting for about 89.8% of all cases, as reported in the most recent study 1. The main characteristics of these types are as follows:

  • Papillary thyroid cancer typically grows slowly with an excellent prognosis.
  • Follicular thyroid cancer is the second most common type, making up about 4.5% of cases, and also has a good prognosis though it can spread more readily through blood vessels.
  • Medullary thyroid cancer originates from C cells that produce calcitonin and accounts for about 1.6% of thyroid cancers; it can be sporadic or hereditary as part of Multiple Endocrine Neoplasia type 2 syndromes.
  • Anaplastic thyroid cancer is the rarest and most aggressive form, representing less than 2% of cases, with a poor prognosis due to its rapid growth and early metastasis. Treatment approaches vary by type but generally include surgery, radioactive iodine therapy, thyroid hormone therapy, and in some cases, targeted therapy or chemotherapy, as outlined in the NCCN Guidelines for Thyroid Carcinoma 1. Some key points to consider in the management of thyroid cancer include:
  • The role of molecular testing for differentiated thyroid carcinoma, as discussed in the NCCN Guidelines Insights 1.
  • The implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, as noted in the NCCN Guidelines Insights 1.
  • The addition of a new targeted therapy option for BRAF V600E–mutated anaplastic thyroid carcinoma, as reported in the NCCN Guidelines Insights 1. Early detection through physical examination and ultrasound is crucial for successful treatment outcomes, especially for the more aggressive types, as emphasized in the ACR Appropriateness Criteria for thyroid disease 1.

From the Research

Types of Thyroid Cancer

  • Papillary thyroid cancer: accounts for approximately 84% of all thyroid cancers 2
  • Follicular thyroid cancer: accounts for approximately 4% of all thyroid cancers 2
  • Oncocytic thyroid cancer: accounts for approximately 2% of all thyroid cancers 2
  • Medullary thyroid cancer: accounts for approximately 4% of all thyroid cancers, arises from parafollicular C cells 2, 3, 4, 5
  • Anaplastic thyroid cancer: accounts for approximately 1% of all thyroid cancers, is an aggressive form of follicular cell-derived thyroid cancer 2, 3, 5
  • Poorly differentiated thyroid cancer: accounts for approximately 5% of all thyroid cancers, is an aggressive form of follicular cell-derived thyroid cancer 2
  • Well-differentiated thyroid cancer: includes papillary, follicular, and oncocytic forms, arises from thyroid follicular cells 2

Rare Phenomenon of Co-existence

  • Co-existence of papillary and medullary thyroid carcinoma: is a rare phenomenon, occurs in less than 1% of all thyroid tumors 4

Classification and Epidemiology

  • Major histological forms of thyroid cancer: include papillary, follicular, medullary, and anaplastic thyroid carcinoma, each with a unique clinical and molecular profile 3
  • Incidence rate of thyroid cancer: is higher in females, has tended to increase over the last several years 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thyroid Cancer: A Review.

JAMA, 2024

Research

Co-existence of Papillary and Medullary Thyroid Carcinoma: Reports of Three Cases.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022

Research

Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.